ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 85700 Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) 0.0237952199154252 -0.023032791
NSC 123111 Mitomycin derivative T 53 0.0237952199154256 0.64165485
NSC 150289 Null 0.0237952199154256 0.070344542
NSC 18335 CINERUBIN B 0.0237952199154256 0.079628325
NSC 269192 8-Trichloromethyldihydroberberine 0.0237952199154256 -0.12919439
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.026296153644827 -0.068223468
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.026296153644827 -0.11914396
NSC 382386 2,4-Imidazolidinedione, 3,3'-(1,6-hexanediyl)bis[5,5- diphenyl- 0.026296153644827 -0.041506575
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.026296153644827 0.056970661
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.026296153644827 -0.21122702
Total:119  Current:58    [First] [Prev] [Next] [Last]